Orli Yogev

Oncology R&D
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Network-driven identification of indisulam neo-substrates for targeted protein degradation.

Network-driven identification of indisulam neo-substrates for targeted protein degradation.

Journal: Molecular omics
Published: September 23, 2025

Response of GEM models of neuroblastoma to cabozantinib assessed by multiparametric magnetic resonance imaging.

Response of GEM models of neuroblastoma to cabozantinib assessed by multiparametric magnetic resonance imaging.

Journal: Neoplasia (New York, N.Y.)
Published: September 14, 2024

Establishment of In Vivo Acquired Resistance to Chemotherapy Via Individual Dose Escalation Treatment Regime.

Establishment of In Vivo Acquired Resistance to Chemotherapy Via Individual Dose Escalation Treatment Regime.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 22, 2022

Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma.

Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma.

Journal: Nature communications
Published: November 03, 2020

Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity.

Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity.

Journal: Blood
Published: December 27, 2019

In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis.

In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis.

Journal: Cancer research
Published: January 18, 2019

Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma.

Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma.

Journal: Cancer research
Published: July 13, 2018

p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance.

p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance.

Journal: Cancer research
Published: July 20, 2015

eIF4EBP3L acts as a gatekeeper of TORC1 in activity-dependent muscle growth by specifically regulating Mef2ca translational initiation.

eIF4EBP3L acts as a gatekeeper of TORC1 in activity-dependent muscle growth by specifically regulating Mef2ca translational initiation.

Journal: PLoS biology
Published: February 07, 2013
Showing 1-9 of 9

Last Updated: 09/26/2026